Home
Market Capitalization of Granules India Ltd

Granules India Ltd
NSE: GRANULES
Market Cap
Key Highlights
- The Market Cap of Granules India Ltd is ₹ 12342 crore as of 21 Feb 25 .
- The Latest Trading Price of Granules India Ltd is ₹ 509 as of 21 Feb 15:30 .
- The Dividend Payouts of Granules India Ltd changed from ₹ 0.25 on Aug 05, 2021 to ₹ 1.5 on Jul 30, 2024 . This represents a CAGR of 34.80% over 6 years.

Granules India Ltd
NSE: GRANULES
Share Price
Market Price of Granules India Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 509 |
20 Feb 2025 | 527.35 |
19 Feb 2025 | 531.75 |
18 Feb 2025 | 517.85 |
17 Feb 2025 | 522.15 |
14 Feb 2025 | 512.55 |
13 Feb 2025 | 542.6 |
12 Feb 2025 | 538.85 |
11 Feb 2025 | 551.3 |
10 Feb 2025 | 569.2 |
SWOT Analysis Of Granules India Ltd
BlinkX Score for Granules India Ltd
Asset Value vs Market Value of Granules India Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Granules India Ltd
Historical P/E Ratio of Granules India Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Granules India Ltd
Historical Revenue of Granules India Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Granules India Ltd
Historical EBITDA of Granules India Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Granules India Ltd
Historical Net Profit of Granules India Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Granules India Ltd
Historical Dividend Payouts of Granules India Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Granules India Ltd
About Granules India Ltd
- Granules India Limited is a large-scale vertically integrated company founded in March 18th, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI) and Finished Dosage (FD).
- With a strong presence across all three vertical, the company has created a leadership position in the off-patent drugs segment along with ensuring a strong presence in first line of defense' products such as Paracetamol, Ibuprofen, Metformin and Guaifenesin.
- The company has a global presence across over 80 countries servicing over 300 customers.
- Granules India is the preferred supplier for some of the world's leading pharma branded and generics companies.
- The company has one of largest PFI and single site FD facilities in the world.
Granules India Ltd News Hub
Granules India Ltd soars 1.63%, up for third straight session
Granules India Ltd rose for a third straight session today. The stock is quoting at Rs 686.45, up 1.
Read more
21 Aug 24
Granules Pharmaceuticals receives USFDA approval for Glycopyrrolate Oral Solution
Granules India announced today that the U.S. Food and Drug Administration (FDA) has approved its Abb
Read more
20 Aug 24
Granules India rises on USFDA nod for oral drug Glycopyrrolate
The ANDA has been filed by Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary o
Read more
20 Aug 24
Granules India receives US FDA nod for depression treatment drug Trazodone
It is bioequivalent and therapeutically equivalent to the reference listed drug Desyrel Tablets of P
Read more
09 Aug 24